We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+3.3%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$181M
AUM Growth
+$1.1M
Cap. Flow
-$73.9M
Cap. Flow %
-40.89%
Top 10 Hldgs %
71.68%
Holding
125
New
27
Increased
27
Reduced
16
Closed
30

Top Buys

Rank Stock Value
1
COHR
Coherent Inc
COHR
+$2.5M
2
AVTR.PRA
Avantor, Inc. Series A Mandatory Convertible Preferred Stock
AVTR.PRA
+$1.86M
3
DZSI
DZS Inc. Common Stock
DZSI
+$1.79M
4
MU icon
Micron Technology
MU
+$1.09M
5
ASPN icon
Aspen Aerogels
ASPN
+$943K

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$3.73M
2
AMGN icon
Amgen
AMGN
+$2.25M
3
AMSC icon
American Superconductor
AMSC
+$1.34M
4
QCOM icon
Qualcomm
QCOM
+$876K
5
RIG icon
Transocean
RIG
+$635K

Sector Composition

Rank Sector Weight
1 Technology 7.59%
2 Healthcare 5.46%
3 Industrials 2.4%
4 Consumer Discretionary 0.95%
5 Communication Services 0.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENTXW
76
DELISTED
Entera Bio Ltd. Warrant
ENTXW
$6K ﹤0.01%
14,030
+87
+0.6% +$54
AMGN icon
77
PUT
Amgen
AMGN
$212B
$5K ﹤0.01%
6,800
-31,200
-82% -$5.59M
BMRN icon
78
CALL
BioMarin Pharmaceuticals
BMRN
$11.9B
$5K ﹤0.01%
+10,500
New +$898K
BMRN icon
79
PUT
BioMarin Pharmaceuticals
BMRN
$11.9B
$5K ﹤0.01%
21,100
+14,489
+219% +$1.24M
ZGNX
80
PUT
DELISTED
Zogenix, Inc.
ZGNX
$4K ﹤0.01%
+14,500
New +$584K
SRDX
81
DELISTED
Surmodics
SRDX
$1K ﹤0.01%
+34
New +$1.44K
ICPT
82
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1K ﹤0.01%
700
– –
ABBV icon
83
PUT
AbbVie
ABBV
$470B
– –
-22,500
Closed -$7K
AMGN icon
84
Amgen
AMGN
$212B
– –
-12,548
Closed -$2.25M
AMSC icon
85
American Superconductor
AMSC
$1.34B
– –
-104,307
Closed -$1.34M
ATEN icon
86
A10 Networks
ATEN
$2.14B
– –
-37,576
Closed -$266K
BCRX icon
87
CALL
BioCryst Pharmaceuticals
BCRX
$2.42B
– –
-16,200
Closed -$49K
BCRX icon
88
PUT
BioCryst Pharmaceuticals
BCRX
$2.42B
– –
-16,200
Closed -$63K
BIIB icon
89
Biogen
BIIB
$31.7B
– –
-15,800
Closed -$3.73M
BIIB icon
90
PUT
Biogen
BIIB
$31.7B
– –
-15,800
Closed -$1.18M
HLF icon
91
PUT
Herbalife
HLF
$1.27B
– –
-1,496
Closed -$2K
KBR icon
92
PUT
KBR
KBR
$4.57B
– –
-10,737
Closed -$4K
NVAX icon
93
CALL
Novavax
NVAX
$1.2B
– –
-2,175
Closed -$2K
QCOM icon
94
CALL
Qualcomm
QCOM
$169B
– –
-48,300
Closed -$62K
QCOM icon
95
Qualcomm
QCOM
$169B
– –
-15,355
Closed -$876K
QCOM icon
96
PUT
Qualcomm
QCOM
$169B
– –
-141,600
Closed -$89K
RIG icon
97
Transocean
RIG
$5.5B
– –
-73,000
Closed -$635K
TPST icon
98
Tempest Therapeutics
TPST
$14.1M
– –
-94
Closed -$276K
VTGN icon
99
VistaGen Therapeutics
VTGN
$9.84M
– –
-5,278
Closed -$203K
TVRD
100
CALL
Tvardi Therapeutics
TVRD
$23M
– –
-442
Closed -$35K
1 2 3
4
5

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
WTG
West Tower Group Richmond, Virginia $32.1M AUM 33.19% 1-Year Est. Return
QCA
Quantify Chaos Advisors Brooklyn, New York $32.1M AUM
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Worth Venture Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Worth Venture Partners held 125 positions worth $181M, up 0.61% from $180M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Worth Venture Partners withdrew a net $73.9M in Q2 2019, closing 30 positions and reducing 16 holdings. Its most notable exit was Biogen, an estimated $3.73M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.6% of assets, up from 5.7% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Worth Venture Partners opened a new position in Coherent Inc worth $2.53M.

  • Worth Venture Partners's largest Q2 2019 buy was Coherent Inc: 18,524 shares worth $2.53M.
  • Worth Venture Partners added most to QuickLogic in Q2 2019, an estimated $726K increase.
  • Worth Venture Partners's biggest Q2 2019 reduction was Nano Dimension, cutting an estimated $582K.
  • Worth Venture Partners fully exited Biogen in Q2 2019, selling an estimated $3.73M.
  • Worth Venture Partners's ten largest holdings make up 72% of its $181M portfolio in Q2 2019.
  • Worth Venture Partners opened 27 new positions and closed 30 in Q2 2019.
  • Worth Venture Partners's portfolio value rose 0.61% quarter-over-quarter to $181M.

Based on Worth Venture Partners's 13F filing for Q2 2019, filed 14 Aug 2019.